Staphylococcus aureus Decolonization as a Prevention Strategy

Infectious Disease Clinics of North America

Volumn 23, Issue 1, 2009, Pages 133-151

  Simor, Andrew E ^a,b   Daneman, Nick ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Decolonization; MRSA; Mupirocin; Prevention; Prophylaxis; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; BACITRACIN; CHLORHEXIDINE; CHLORTETRACYCLINE; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; FUSIDIC ACID; GENTAMICIN; HEXACHLOROPHENE; LYSOSTAPHIN; MERSACIDIN; MINOCYCLINE; NEOMYCIN; NOVOBIOCIN; POLYMYXIN B; PSEUDOMONIC ACID; RIFAMPICIN; STAPHYLOCOCCUS VACCINE; SULFATHIAZOLE; SULFONAMIDE; TEA TREE OIL; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTISEPSIS; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CROSS-SECTIONAL STUDY; DAY CARE; DECUBITUS; DEVICE INFECTION; EPIDEMIC; HEMODIALYSIS PATIENT; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PERITONEAL DIALYSIS; PREOPERATIVE TREATMENT; RECURRENT INFECTION; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; CARRIER STATE; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 58149180099     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2008.10.006     Document Type: Review

References (100)

1. Williams R.E.O. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 27 (1963) 56-71
2. Arnold M.S., Dempsey J.M., Fishman M., et al. The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol 23 (2002) 69-76
3. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
4. Kallen A.J., Wilson C.T., and Larson R.J. Perioperative intranasal mupirocin for the prevention of surgical site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 26 (2005) 916-922
5. West S.K., Plantenga M.S., Strausbaugh L.J., et al. Use of decolonization to prevent staphylococcal infections in various healthcare settings: results of an Emerging Infections Network survey. Infect Control Hosp Epidemiol 28 (2007) 1111-1113
6. Kluytmans J., van Belkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10 (1997) 505-520
7. Graham III P.L., Lin S.X., and Larson E.L. A US population-based survey of Staphylococcus aureus colonization. Ann Intern Med 144 (2006) 318-325
8. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 197 (2008) 1226-1234
9. Boe J., Solberg C.O., Vogelsang T.M., et al. Perineal carriers of staphylococci. Br Med J 5404 (1964) 280-281
10. Boyce J.M., Havill N.L., and Maria B. Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43 (2005) 5992-5995
11. Nilsson P., and Ripa T. Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol 44 (2006) 3334-3339
12. Wertheim H.F.L., Melles D.C., Vos M.C., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5 (2005) 751-762
13. Davis K.A., Stewart J.J., Crouch H.K., et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 39 (2004) 776-782
14. von Eiff C., Becker K., Machka K., et al. Nasal carriage as a source of Staphylococus aureus bacteremia. N Engl J Med 344 (2001) 11-16
15. Huang S.S., and Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36 (2003) 281-285
16. Perl T.M., and Golub J.E. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann. Pharmacother 32 (1998) S7-S16
17. Wertheim H.F.L., Vos M.C., Ott A., et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364 (2004) 703-705
18. Luzar M.A., Coles G.A., Faller B., et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 322 (1990) 505-509
19. Wenzel R.P., and Perl T.M. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 31 (1995) 13-24
20. Kluytmans J.A.J.W., Mouton J.W., Ijzerman E.P.F., et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 171 (1995) 216-219
21. Kalmeijer M.D., van Nieuwland-Bollen E., Bogaers-Hofman D., et al. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical site infections in orthopedic surgery. Infect Control Hosp Epidemiol 21 (2000) 319-323
22. Pujol M., Peña C., Pallares R., et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 100 (1996) 509-516
23. Boyce J.M. Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus: proceeding with caution. Infect Control Hosp Epidemiol 17 (1996) 775-779
24. Houck P.W., Nelson J.D., and Kay J.L. Fatal septicemia due to S aureus 502A. Report of a case and review of the infectious complications of bacterial interference programs. Am J Dis Child 123 (1972) 45-48
25. Wheat L.J., Kohler R.B., Luft F.C., et al. Long-term effect of rifampin on nasal carriage of coagulase-positive staphylococci. Rev Infect Dis 5 Suppl 3 (1983) S459-S462
26. Peterson L.R., Quick J.N., Jensen B., et al. Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S. aureus colonization. Arch Intern Med 150 (1990) 2151-2155
27. Walsh T.J., Standiford H.C., Reboli A.C., et al. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother 37 (1993) 1134-1142
28. Muder R.R., Boldin M., Brennen C., et al. A controlled trial of rifampicin, minocycline, and rifampicin plus minocycline for eradication of methicillin-resistant Staphylococcus aureus in long-term care patients. J Antimicrob Chemother 34 (1994) 189-190
29. Parras F., del Carmen Guerrero M., Bouza E., et al. Comparative study of mupirocin and oral cotrimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 39 (1995) 175-179
30. Watanakunakorn C., Axelson C., Bota B., et al. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. Am J Infect Control 23 (1995) 306-309
31. Harbarth S., Dharan S., Liassine N., et al. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 43 (1999) 1412-1416
32. Martin J.N., Perdreau-Remington F., Kartalija M., et al. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. J Infect Dis 180 (1999) 896-899
33. Chang S.-C., Hsieh S.-M., Chen M.-L., et al. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains. Diagn Microbiol Infect Dis 36 (2000) 131-136
34. Mody L., Kauffman C.A., McNeil S.A., et al. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37 (2003) 1467-1474
35. Dryden M.S., Dailly S., and Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 56 (2004) 283-286
36. Simor A.E., Phillips E., McGeer A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 44 (2007) 178-185
37. Soto N.E., Vaghjimal A., Stahl-Avicolli A., et al. Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization. Infect Control Hosp Epidemiol 20 (1999) 351-353
38. Doebbeling B.N., Breneman D.L., Neu H.C., et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis 17 (1993) 466-474
39. Fernandez C., Gaspar C., Torrellas A., et al. A double-blind, randomized, placebo-controlled trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. J Antimicrob Chemother 35 (1995) 399-408
40. Reagan D.R., Doebbeling B.N., Pfaller M.A., et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 114 (1991) 101-106
41. Pérez-Fontán M., García-Falcón T., Rosales M., et al. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results. Am J Kidney Dis 22 (1993) 708-712
42. Laupland K.B., and Conly J.M. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 37 (2003) 933-938
43. Cederna J.E., Terpenning M.S., Ensberg M., et al. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol 11 (1990) 13-16
44. Wertheim H.F.L., Verveer J., Boelens H.A.M., et al. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob Agents Chemother 49 (2005) 1465-1467
45. Miller M.A., Dascal A., Portnoy J., et al. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 17 (1996) 811-813
46. Vasquez J.E., Walker E.S., Franzus B.W., et al. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans Affairs hospital. Infect Control Hosp Epidemiol 21 (2000) 459-464
47. Pérez-Fontán M., Rosales M., Rodríguez-Carmona A., et al. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 39 (2002) 337-341
48. Kruszewska D., Sahl H.-G., Bierbaum G., et al. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother 54 (2004) 648-653
49. Kokai-Kun J.F., Walsh S.M., Chanturiya T., et al. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 47 (2003) 1589-1597
50. Falagas M.E., Bliziotis I.A., and Fragoulis K.N. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control 35 (2007) 106-114
51. Loeb M., Main C., Walker-Dilks C., et al. Antimicrobial agents for treating methicillin-resistant Staphylococcus aureus. Cochrane Database Syst Rev 4 (2003) CD003340
52. Harbarth S., Liassine N., Dharan S., et al. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 31 (2000) 1380-1385
53. Kluytmans J.A.J.W., Mouton J.W., VandenBergh M.F.Q., et al. Reduction of surgical site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 17 (1996) 780-785
54. Gernaat-van der Sluis A.J., Hoogenboom-Verdegaal A.M., Edixhoven P.J., et al. Prophylactic mupirocin could reduce orthopedic wound infections: 1044 patients treated with mupirocin compared with 1260 historical controls. Acta Orthop Scand 69 (1998) 412-414
55. Yano M., Doki Y., Inoue M., et al. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 30 (2000) 16-21
56. Cimochowski G.E., Harostock M.D., Brown R., et al. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 71 (2001) 1572-1579
57. Wilcox M.H., Hall J., Pike H., et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 54 (2003) 196-201
58. Horiuchi A., Nakayama Y., Kajiyama M., et al. Nasopharyngeal decolonization of methicillin-resistant Staphylococcus aureus can reduce PEG peristomal wound infection. Am J Gastroenterol 101 (2006) 274-277
59. Thomas S., Cantrill S., Waghorn D.J., et al. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus. Aliment Pharmacol Ther 25 (2007) 593-597
60. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 (2002) 1871-1877
61. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 35 (2002) 353-358
62. Suzuki Y., Kamigaki T., Fujino Y., et al. Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery. Br J Surg 90 (2003) 1072-1075
63. Konvalinka A., Errett L., and Fong I.W. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect 64 (2006) 162-168
64. Segers P., Speekenbrink R.G.H., Ubbink D.T., et al. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA 296 (2006) 2460-2466
65. Dupeyron C., Campillo B., Richardet J.-P., et al. Long-term efficacy of mupirocin in the prevention of infections with methicillin-resistant Staphylococcus aureus in a gastroenterology unit. J Hosp Infect 63 (2006) 385-392
66. Wertheim H.F.L., Vos M.C., Ott A., et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients. A randomized study. Ann Intern Med 140 (2004) 419-425
67. Yu V.L., Goetz A., Wagener M., et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 315 (1986) 91-96
68. Tacconelli E., Carmeli Y., Aizer A., et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 37 (2003) 1629-1638
69. Boelaert J.R., De Smedt R.A., De Baere Y.A., et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 4 (1989) 278-281
70. Sesso R., Barbosa D., Leme I.L., et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 9 (1998) 1085-1092
71. The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit site infection during peritoneal dialysis. J Am Soc Nephrol 7 (1996) 2403-2408
72. Bernardini J., Bender F., Florio T., et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16 (2005) 539-545
73. Daum R.S. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 357 (2007) 380-390
74. Ellis M.W., Hospenthal D.R., Dooley D.P., et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 39 (2004) 971-979
75. Hedström S.A. Recurrent staphylococcal furunculosis. Bacteriological findings and epidemiology. Scand J Infect Dis 13 (1981) 115-119
76. Tuazon C.U. Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. Am J Med 75 (1984) 166-171
77. Hedström S.A. Treatment and prevention of recurrent staphylococcal furunculosis: clinical and bacteriological follow-up. Scand J Infect Dis 17 (1985) 55-58
78. Aminzadeh A., Demircay Z., Ocak K., et al. Prevention of chronic furunculosis with low-dose azithromycin. J Dermotolog Treat 18 (2007) 105-108
79. Wiese-Posselt M., Heuck D., Draeger A., et al. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis 44 (2007) e88-e95
80. Raz R., Miron D., Colodner R., et al. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med 156 (1996) 1109-1112
81. Ellis M.W., Griffith M.E., Dooley D.P., et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother 51 (2007) 3591-3598
82. Rahimian J., Khan R., and LaScalea K.A. Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections?. Infect Control Hosp Epidemiol 28 (2007) 1415-1416
83. Verhoef J., Beaujean D., Blok H., et al. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 18 (1999) 461-466
84. Hill R.L.R., Duckworth G.J., and Casewell M.W. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 22 (1988) 377-384
85. Girou E., Pujade G., Legrand P., et al. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 27 (1998) 543-550
86. Hitomi S., Kubota M., Mori N., et al. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 46 (2000) 123-129
87. Koitilainen P., Routamaa M., Peltonen R., et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 161 (2001) 859-863
88. Silvestri L., Milanese M., Oblach L., et al. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 30 (2002) 391-399
89. Tomic V., Svetina S.P., Trinkaus D., et al. Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med 164 (2004) 2038-2043
90. Sandri A.M., Dalarosa M.G., Ruschel de Alcântara L., et al. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 27 (2006) 185-187
91. Cerdá E., Abella A., de la Cal M.A., et al. Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit. A 9-year prospective study. Ann Surg 245 (2007) 397-407
92. Ridenour G., Lampen R., Federspiel J., et al. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 28 (2007) 1155-1161
93. Raineri E., Crema L., De Silvestri A., et al. Methicillin-resistant Staphylococcus aureus control in an intensive care unit: a 10-year analysis. J Hosp Infect 67 (2007) 308-315
94. Robiscek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148 (2008) 409-418
95. Harbarth S., Frankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299 (2008) 1149-1157
96. Zinderman C.E., Conner B., Malakooti M.A., et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 10 (2004) 941-944
97. Shahin R., Johnson I.L., Jamieson F., et al. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med 153 (1999) 864-868
98. Regev-Yochay G., Rubinstein E., Barzilai A., et al. Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg Infect Dis 11 (2005) 453-456
99. Nguyen D.M., Mascola L., and Bancroft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 11 (2005) 526-532
100. Rihn J.A., Posfay-Barbe K., Harner C.D., et al. Community-acquired methicillin-resistant Staphylococcus aureus outbreak in a local high school football team. Unsuccessful interventions. Pediatr Infect Dis J 24 (2005) 841-843